DEVELOPMENT OF A REGULATORY POST-MARKETING STUDIES DATABASE

被引：0
|
作者：
Caron, M. [1 ]
Mouchet, J. [1 ]
Emery, M. P.
Longin, J. [1 ,2 ]
Maier, W. C. [3 ]
机构：
[1] MAPI Res Trust, Lyon, France
[2] MAPI, Lyon, France
[3] MAPI EPI, Lyon, France
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)73180-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A24 / A24
页数：1
相关论文
共 50 条
  • [21] Drug utilization studies: Their importance for post-marketing surveillance
    Castro, Lia C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S95 - S96
  • [22] Post-marketing safety of Adagrasib: a disproportionality analysis based on the FAERS database
    Shi, Zheng
    Yu, Xiayao
    Zhao, Yifan
    Shao, Keda
    Xu, Chunwei
    Song, Zhengbo
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [23] Antidepressants and Movement Disorders: A post-marketing study in the world pharmacovigilance database
    Revet, A.
    Montastruc, F.
    Roussin, A.
    Raynaud, J. P.
    Lapeyre-Mestre, M.
    Nguyen, T. T. H.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 97 - 98
  • [24] Predictive value of the efficacy of glaucoma medications in regulatory trials: Phase I–III to post-marketing studies
    W C Stewart
    J N Jenkins
    Eye, 2008, 22 : 985 - 988
  • [25] Impact of Scheduled Post-Marketing Safety Summary Analyses on Regulatory Actions
    Sekine, Shohko
    Pinnow, Ellen E.
    Kurtzig, Rebecca
    Wu, Eileen
    Marni, Hall
    Dal Pan, Gerald
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 443 - 444
  • [26] Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies
    Spelsberg, Angela
    Prugger, Christof
    Doshi, Peter
    Ostrowski, Kerstin
    Witte, Thomas
    Huesgen, Dieter
    Keil, Ulrich
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
  • [27] New Japanese Regulatory Frameworks for Post-Marketing Management of Pharmaceutical Products
    Takamura, Kento
    Tachibana, Keisuke
    Kusakabe, Tetsuya
    Nakai, Kiyohito
    Tsutsumi, Yasuo
    Kondoh, Masuo
    PHARMACEUTICAL RESEARCH, 2020, 37 (07)
  • [28] FDA regulatory routes and clinical post-marketing requirements for personalized medicines
    Vossen, Carla
    Albano, Jessica
    Isherwood, Tara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 229 - 230
  • [29] New Japanese Regulatory Frameworks for Post-Marketing Management of Pharmaceutical Products
    Kento Takamura
    Keisuke Tachibana
    Tetsuya Kusakabe
    Kiyohito Nakai
    Yasuo Tsutsumi
    Masuo Kondoh
    Pharmaceutical Research, 2020, 37
  • [30] Post-marketing observational studies: my experience in the drug industry
    不详
    BRITISH MEDICAL JOURNAL, 2012, 344
12345